EAN News

EAN pages strives to present one country every month to the readers of the EAN pages. We have seen presentations from Albania, Croatia, Denmark, Estonia, Finland, Georgia, and Ireland so far and I would draw your attention to these wonderful articles in our newsblog. This month we have Latvia and in December it will be Moldovia. The country where the EAN congresses take place (so far Germany and Denmark) are even presented in a series of articles covering special aspects of the development of local neurology. The top neurologists from these countries take their time to present important aspects of their country like Denmark did before the Copenhagen congress in 2016. In a series of seven articles they have presented the state of the art and research in their country concerning basic MS research, pain, dementia, clinical MS research, cerebral blood flow research, clinical neurophysiology and headache. The care structures for patients and how research is helping to develop new treatments and new innovations are outlined and one can learn from their success. Whenever I read their presentations it reminds me to the rich history of neurology in Europe. All the different countries were able to show their particular contribution to the field and the achievements they have reached to provide better patient care.

David B. Vodušek (DV): As a senior experienced European neurologist, can you illustrate the role you give to EAN within the community of European Neurologists? Claudia Sommer (CS): The EAN is the umbrella society for the community of European Neurologists, and I am more than glad that after many years, we have achieved to build one strong society.

It is a dream of neurologists to cure degenerative diseases. The big brothers, Alzheimer’s and Parkinson’s disease have always been a huge burden of the population but are now, in the millennium of increasing population age becoming a scourge of humanity. While everybody is acknowledging this, both PD (1) and AD (2) communities of clinician researchers and basic researchers are preparing to attack the problem fundamentally frequently unnoticed by the general neurology community.

It is a dream of neurologists to cure degenerative diseases. The big brothers, Alzheimers’ and Parkinsons’ disease have always been a huge burden of the population but are now, in the millennium of increasing population age becoming a scourge of humanity. While everybody is acknowledging this, both PD1 and AD2 communities of clinician researchers and basic researchers are preparing to attack the problem fundamentally frequently unnoticed by the general neurology community.

David B. Vodušek (DV): EFNS has been a founding member of EBC, and its successor EAN continues to be an actively involved member society. Nevertheless, many of our readers would appreciate to hear your views on what is EBC, its mission and how it gets this accomplished? David Nutt (DN): The ultimate reason behind all EBC actions is to improve the condition of those living with brain disorders and to reduce prevalence of brain diseases all together.

David Vodušek (DV): The AFAN, like the EAN, addresses and covers the neurological interest of a continent. Can you explain to the readers of the EANpages how was the AFAN created and why? Mansour Ndiaye (MN): Delegates from over 30 countries in Africa representing the interests of their national neurologic societies and associations met in Dakar, Senegal, over the weekend of August 29-30, 2015.

Video: Voices of the Congress – 2nd EAN Congress Copenhagen 2016 was last modified: August 31st, 2016 by Editor… Continue Reading

The 2nd Congress of the European Academy of Neurology, held in Copenhagen, May 28-31, 2016, was attended by a total of 5521 participants. About 1500 (27.2%) participants filled in the survey to receive their certificate of attendance. Ten participants out… Continue Reading

Prof. Cesare Fieschi passed away last June in Rome (Italy) at the age of 84.